menu
    • menu

    Company profile for Cerebral Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Led by experts in the fields of Brain Drug and Device Development, Cerebral Therapeutics™ addresses chronic neurological diseases using novel and proprietary drugs administered directly to the brain. By bypassing the blood-brain barrier, Cerebral’s therapies are designed to maximize medication efficacy while greatly reducing systemic exposure and enhancing drug regimen compliance. To provide a unique approach to improve...
    Led by experts in the fields of Brain Drug and Device Development, Cerebral Therapeutics™ addresses chronic neurological diseases using novel and proprietary drugs administered directly to the brain. By bypassing the blood-brain barrier, Cerebral’s therapies are designed to maximize medication efficacy while greatly reducing systemic exposure and enhancing drug regimen compliance. To provide a unique approach to improve the lives of patients suffering from chronic neurological diseases, particularly those for whom oral and I.V. infused medicines are either not effective, and/or are limited by systemic medication side effects.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Cerebral TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    12635 E. Montview Blvd. Aurora, CO 80010
    Telephone
    Telephone
    303 547 3448
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.cerebraltherapeutics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Mental health startup Cerebral to lay off about 15% of workforce
    Mental health startup Cerebral to lay off about 15% of workforce

    27 Feb 2023

    // REUTERS

    https://www.reuters.com/business/mental-health-startup-cerebral-lay-off-about-15-workforce-2023-02-28/

    REUTERS
    27 Feb 2023
    Share Share
    Cerebral Therapeutics Names Julie Foster as Chief Operating Officer
    Cerebral Therapeutics Names Julie Foster as Chief Operating Officer

    25 Jan 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230125005636/en

    BUSINESSWIRE
    25 Jan 2023
    Share Share
    Getting Cerebral: VCs bet $40M on epilepsy implant development
    Getting Cerebral: VCs bet $40M on epilepsy implant development

    05 Jul 2022

    // Nick Paul Taylor FIERCEPHARMA

    https://www.fiercepharma.com/pharma/getting-cerebral-vcs-bet-40m-epilepsy-implant-development

    Nick Paul Taylor FIERCEPHARMA
    05 Jul 2022
    Share Share
    Cerebral Therapeutics, Inc. Secures $40 Million Series C Financing
    Cerebral Therapeutics, Inc. Secures $40 Million Series C Financing

    28 Jun 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220628005102/en

    BUSINESSWIRE
    28 Jun 2022
    Share Share
    Cerebral and Alto Neuroscience Enter into Strategic Collab to Launch First-Ever
    Cerebral and Alto Neuroscience Enter into Strategic Collab to Launch First-Ever

    16 Dec 2021

    // BIOSPACE

    https://www.biospace.com/article/releases/cerebral-and-alto-neuroscience-enter-into-strategic-collaboration-to-launch-first-ever-decentralized-study-in-precision-psychiatry/

    BIOSPACE
    16 Dec 2021
    Share Share
    Cerebral, Alto Neuroscience Collaborate to Launch Study in Precision Psychiatry
    Cerebral, Alto Neuroscience Collaborate to Launch Study in Precision Psychiatry

    16 Dec 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211216005237/en

    BUSINESSWIRE
    16 Dec 2021
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search